The DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study
Abstract
Background— Visceral adipose tissue (VAT) compartments may confer increased metabolic risk. The incremental utility of measuring both visceral and subcutaneous abdominal adipose tissue (SAT) in association with metabolic risk factors and underlying heritability has not been well described in a population-based setting. Methods and Results— Participants (n=3001) were drawn from the Framingham Heart Study (48% women; mean age, 50 years), were free of clinical cardiovascular disease, and underwent multidetector computed tomography assessment of SAT and VAT volumes between 2002 and 2005. Metabolic risk factors were examined in relation to increments of SAT and VAT after multivariable adjustment. Heritability was calculated using variance-components analysis. Among both women and men, SAT and VAT were significantly associated with blood pressure, fasting plasma glucose, triglycerides, and high-density lipoprotein cholesterol and with increased odds of hypertension, impaired fasting glucose, diabetes mellitus, and metabolic syndrome ( P range <0.01). In women, relations between VAT and risk factors were consistently stronger than in men. However, VAT was more strongly correlated with most metabolic risk factors than was SAT. For example, among women and men, both SAT and VAT were associated with increased odds of metabolic syndrome. In women, the odds ratio (OR) of metabolic syndrome per 1–standard deviation increase in VAT (OR, 4.7) was stronger than that for SAT (OR, 3.0; P for difference between SAT and VAT <0.0001); similar differences were noted for men (OR for VAT, 4.2; OR for SAT, 2.5). Furthermore, VAT but not SAT contributed significantly to risk factor variation after adjustment for body mass index and waist circumference ( P ≤0.01). Among overweight and obese individuals, the prevalence of hypertension, impaired fasting glucose, and metabolic syndrome increased linearly and significantly across increasing VAT quartiles. Heritability values for SAT and VAT were 57% and 36%, respectively. Conclusions— Although both SAT and VAT are correlated with metabolic risk factors, VAT remains more strongly associated with an adverse metabolic risk profile even after accounting for standard anthropometric indexes. Our findings are consistent with the hypothesized role of visceral fat as a unique, pathogenic fat depot. Measurement of VAT may provide a more complete understanding of metabolic risk associated with variation in fat distribution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Body fat has better predictive validity on the development of the metabolic syndrome192 and cardiovascular disease risk193 than BMI.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [192]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, ectopic fat depots, such as epicardial and perivascular fat, might exert local pathogenic effects on heart and blood vessels.[7][8][9]”
From Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial (2025) · cites this paper as [7]
Experimental — accuracy not yet measuredIn the citing paper
“In addition to the association between triglyceride levels and BMI, the Framingham Heart Study 155 reported strong associations of triglyceride levels with both subcutaneous abdominal adipose tissue and visceral adipose tissue in men and women (mean age 50 years).”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [155]
In the citing paper
“Thus, although it is clear that excess adiposity is associated with elevated triglyceride levels, visceral adiposity is a greater contributor than subcutaneous adipose tissue.155,156”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [155]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Prevalence of Overweight and Obesity in the United States
Crespo, C. J., & Smit, E. (2003) · Human Kinetics eBooks · doi:10.5040/9781718206601.ch-001 · Cited by 4,382
Heart Disease and Stroke Statistics—2006 Update
Writing Group Members, Thom, T., Haase, N., Rosamond, W. D., Howard, V. J., Rumsfeld, J. S., Manolio, T. A., Zheng, Z., Flegal, K. M., O’Donnell, C. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,453
Self-citationOverweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
Multipoint Quantitative-Trait Linkage Analysis in General Pedigrees
Almasy, L. A., & Blangero, J. (1998) · The American Journal of Human Genetics · doi:10.1086/301844 · Cited by 3,021
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961
Flagged first, then by citations
1 of the 78 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,013
Wang, H., Chen, Y., Sun, G., Jia, P., Qian, H. R., & Sun, Y. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1444901 · Cited by 149
“tive substances that contribute to inflammation, insulin resistance, and the risk of developing metabolic traits, the VAT compartment has been assumed to be a unique pathogenic fat depot [51].”
BackgroundHypertension in Obesity and the Impact of Weight Loss
Cohen, J. B. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0912-4 · Cited by 147
Lee, J., Pedley, A., Hoffmann, U., Massaro, J. M., Levy, D. A., & Long, M. T. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.02.002 · Cited by 148
Self-citationPersistent Diet-Induced Obesity in Male C57BL/6 Mice Resulting from Temporary Obesigenic Diets
Guo, J., Jou, W., Gavrilova, O., & Hall, K. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005370 · Cited by 147
Nam, S. Y., Choi, I. J., Ryu, K. H., Park, B. J., Kim, H. B., & Nam, B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.019 · Cited by 147
Metabolic syndrome: its history, mechanisms, and limitations
Oda, E. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0309-6 · Cited by 147
Miyoshi, M., Ogawa, A., Higurashi, S., & Kadooka, Y. (2013) · European Journal of Nutrition · doi:10.1007/s00394-013-0568-9 · Cited by 144
Feleke, Y., Yadeta, D., Geletew, T. K., Gelibo, T., Getachew, T., Lemu, K. A., Challa, F., Mengesha, A. B., Degefu, F. S., Defar, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194819 · Cited by 145
Maternal weight and body composition in the first trimester of pregnancy
Fattah, C., Farah, N., Barry, S. C., O’Connor, N., Stuart, B., & Turner, M. J. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016341003801706 · Cited by 144
Sex differences in metabolism and cardiometabolic disorders
Krishnan, K. C., Mehrabian, M., & Lusis, A. J. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000536 · Cited by 153
Mechanisms Linking Excess Adiposity and Carcinogenesis Promotion
Pérez-Hernández, A. I., Catalán, V., Gómez‐Ambrosi, J., RodrÃguez, A., & Frühbeck, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00065 · Cited by 148
Shi, Z., Zhao, C. L., Guo, X., Ding, H., Cui, Y., Shen, R., & Liu, J. (2014) · Endocrinology · doi:10.1210/en.2013-2046 · Cited by 143
“Women from the GDM group had higher glucose levels at each oral glucose tolerance test (OGTT) time 1984 Shi et al miR-222 and Insulin Resistance of GDM Endocrinology, May 2014, 155(5):1982–1990”
BackgroundInfluentialBays, H. E. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000093 · Cited by 142
Manifestations and mechanisms of myocardial lipotoxicity in obesity
Sletten, A. C., Peterson, L. R., & Schaffer, J. E. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12728 · Cited by 148
Siskind, D., Hahn, M., Correll, C. U., Fink‐Jensen, A., Russell, A. W., Bak, N., Broberg, B. V., Larsen, J., Ishøy, P. L., Vilsbøll, T., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13522 · Cited by 144
Sex differences in risk factors for vascular contributions to cognitive impairment & dementia
Gannon, O. J., Robison, L. S., Custozzo, A. J., & Zuloaga, K. L. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.11.014 · Cited by 146
Intramuscular Fat and Associations With Metabolic Risk Factors in the Framingham Heart Study
Therkelsen, K. E., Pedley, A., Speliotes, E. K., Massaro, J. M., Murabito, J. M., Hoffmann, U., & Fox, C. S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301009 · Cited by 140
“We have consistently observed stronger associations between ectopic fat depots and metabolic risk factors in women as compared with men.(3) Although the pathogenesis of this remains uncertain, potential mechanisms include higher rates of delivery of hepatic free fatty acids in women as compared with men,(23) sex diffe…”
BackgroundSelf-citationMaternal obesity and infant outcomes
Ruager-Martin, R., Hyde, M. J., & Modi, N. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.08.007 · Cited by 139
Elffers, T. W., de Mutsert, R., Lamb, H. J., de Roos, A., Willems van Dijk, K., Rosendaal, F. R., Jukema, J. W., & Trompet, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185403 · Cited by 167
Seifarth, J., McGowan, C. L. M., & Milne, K. J. (2012) · Gender Medicine · doi:10.1016/j.genm.2012.10.001 · Cited by 144
McCrindle, B. W., Mietus‐Snyder, M., Steinberger, J., Daniels, S. R., Eckel, R. H., & Hayman, L. L. (2009) · Cited by 138
Bamberg, F., Hetterich, H., Rospleszcz, S., Lorbeer, R., Auweter, S., Schlett, C. L., Schafnitzel, A., Bayerl, C., Schindler, A., Saam, T., et al. (2016) · Diabetes · doi:10.2337/db16-0630 · Cited by 144
“With this, we also confirm earlier findings in the Framingham Heart Study (39) using computed tomography, indicating that visceral adipose tissue is more strongly associated with an adverse metabolic risk profile even after accounting for standard anthropometric indexes.”
ResultAbdominal Superficial Subcutaneous Fat
Golan, R., Shelef, I., Rudich, A., Gepner, Y., Shemesh, E., Chassidim, Y., Harman‐Boehm, I., Henkin, Y., Schwarzfuchs, D., Avraham, S. B., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1583 · Cited by 137
Ohki, T., Tateishi, R., Shiina, S., Goto, E., Sato, T., Nakagawa, H., Masuzaki, R., Goto, T., Hamamura, K., Kanai, F., et al. (2009) · Gut · doi:10.1136/gut.2008.164053 · Cited by 137
Perivascular Adipose Tissue and Coronary Atherosclerosis: from Biology to Imaging Phenotyping
Lin, A., Dey, D., Wong, D. T. L., & Nerlekar, N. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0817-3 · Cited by 139
Aschbacher, K., Kornfeld, S., Picard, M. A., Puterman, E. M., Havel, P. J., Stanhope, K. L., Lustig, R. H., & Epel, E. S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.003 · Cited by 143
“Waistline and truncal fat are proxies but not precise measures of visceral fat; nonetheless, both visceral and subcutaneous fat are associated with heightened metabolic risk (Fox et al., 2007).”
Adipose tissue browning in mice and humans
Herz, C. T., & Kiefer, F. W. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0598 · Cited by 144
Christiansen, B. A., Kopperdahl, D. L., Kiel, D. P., Keaveny, T. M., & Bouxsein, M. L. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.287 · Cited by 135
Chu, A. Y., Deng, X., Fisher, V. A., Drong, A., Zhang, Y., Feitosa, M. F., Liu, C.-T., Weeks, O., Choh, A. C., Duan, Q., et al. (2016) · Nature Genetics · doi:10.1038/ng.3738 · Cited by 137
Self-citationDeanfield, J., Lincoff, A. M., Kahn, S. E., Emerson, S. S., Lingvay, I., Scirica, B. M., Plutzky, J., Kushner, R. F., Colhoun, H. M., Hovingh, G. K., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01375-3 · Cited by 143
Bone Marrow Adiposity: Basic and Clinical Implications
Sebo, Z. L., Rendina-Ruedy, E., Ables, G. P., Lindskog, D. M., Rodeheffer, M. S., Fazeli, P. K., & Horowitz, M. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00138 · Cited by 143
Perivascular adipose tissue and vascular disease
Britton, K. A., & Fox, C. S. (2011) · Clinical Lipidology · doi:10.2217/clp.10.89 · Cited by 135
Self-citationObese Patients With a Binge Eating Disorder Have an Unfavorable Metabolic and Inflammatory Profile
Succurro, E., Segura‐Garcìa, C., Ruffo, M., Caroleo, M., Rania, M., Aloi, M., Fazio, P. D., Sesti, G., & Arturi, F. (2015) · Medicine · doi:10.1097/md.0000000000002098 · Cited by 138
“21,31,32 In obese patients, visceral adipose tissue accumulation has been associated with an increased production of free fatty acids, interleukin-6, tumor necrosis factor-a , hs-CRP, and a decreased production of adiponectin, each of which may contribute to insulin resistance.”
Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities
Vyas, V. S., & Lambiase, P. D. (2019) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.76.2 · Cited by 137
“Epicardial Fat, Adipose Tissue Biology and AF Given adipose tissue distribution appears to be a key factor in determining cardiovascular risk, it is no surprise that the role of distinct adipose tissue depots is of intense interest.(43) With more sophisticated cross-sectional imaging modalities such as CT and MRI bein…”
BackgroundShin, S. Y., Yong, H. S., Lim, H. E., Na, J. O., CHOI, C. U., Choi, J., Kim, S. H., Kim, J. W., Kim, E. J., PARK, S. W., et al. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01993.x · Cited by 132
Sam, S., Haffner, S. M., Davidson, M. H., D’Agostino, R. B., Feinstein, S. B., Kondos, G. T., Pérez, A., & Mazzone, T. (2008) · Diabetes · doi:10.2337/db08-0157 · Cited by 130
Self-citationChildhood obesity, bone development, and cardiometabolic risk factors
Pollock, N. K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.03.016 · Cited by 129
“Given that metabolic abnormalities are more strongly associated with central rather than total adiposity (Fox et al., 2007), it is possible that this typeof fat accumulationcouldaffectdevelopingbonedistinctly,which could be another potential explanation for the conflicting pediatric data of the…”
BackgroundLi, Y., Zhu, W., Gong, J., Zhang, W., Gu, L., Guo, Z., Cao, L., Shen, B., Li, N., & Li, J. (2014) · Colorectal Disease · doi:10.1111/codi.12798 · Cited by 129
Carr, L. J., Bartee, R. T., Dorozynski, C., Broomfield, J. F., Smith, M. L., & Smith, D. T. (2008) · Preventive Medicine · doi:10.1016/j.ypmed.2007.12.005 · Cited by 118
Sleep Duration and Five-Year Abdominal Fat Accumulation in a Minority Cohort: The IRAS Family Study
Hairston, K. G., Bryer-Ash, M., Norris, J. M., Haffner, S., Bowden, D. W., & Wagenknecht, L. E. (2010) · Sleep · doi:10.1093/sleep/33.3.289 · Cited by 128
Melone, M., Wilsie, L. C., Palyha, O. C., Strack, A. M., & Rashid, S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.064 · Cited by 134
Ahl, S., Guenther, M. A., Zhao, S., James, R. G., Marks, J., Szabó, A., & Kidambi, S. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2765 · Cited by 129
Han, L., You, D., Ma, W., Astell‐Burt, T., Feng, X., Duan, S., & Qi, L. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.13131 · Cited by 128
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
Dedov, I. I., Shestakova, M. V., Mel'nichenko, G. A., Mazurina, N. V., Andreeva, E. N., Bondarenko, I. Z., Руслановна, Г. З., Dzgoeva, F. K., Елисеев, М. С., Ershova, E. V., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12714 · Cited by 163
Pediatric body composition analysis with dual-energy X-ray absorptiometry.
Helba, M., & Binkovitz, L. A. (2009) · Pediatric Radiology · doi:10.1007/s00247-009-1247-0 · Cited by 127
Oh, J., Sung, Y., & Lee, H. J. (2013) · Obesity · doi:10.1002/oby.20096 · Cited by 154
“Women with PCOS have excessive visceral fat accumulation, even if they are of normal weight, and visceral adiposity is associated with more pronounced hyperandrogenism and insulin resistance than subcutaneous or peripheral fat accumulation (12,23,24).”
Clinical problems caused by obesity
Kyrou, I., Randeva, H. S., Barber, T., Tsigos, C., Kaltsas, G. A., & Weickert, M. O. (2022) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33841351 · Cited by 127
Visser, A. W., de Mutsert, R., le Cessie, S., den Heijer, M., Rosendaal, F. R., Kloppenburg, M., & NEO Study Group (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.02.387 · Cited by 126
Fatty Liver, Abdominal Visceral Fat, and Cardiometabolic Risk Factors
Liu, J., Fox, C. S., Hickson, D. A., Bidulescu, A., Carr, J. J., & Taylor, H. A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.234062 · Cited by 126
Self-citationKong, Z., Sun, S., Liu, M., & Shi, Q. (2016) · Journal of Diabetes Research · doi:10.1155/2016/4073618 · Cited by 133
“Excessive accumulation of body fat, especially intraabdominal visceral fat, is identified as a potent independent predictor for hyperlipidemia, insulin resistance, and metabolic syndrome, whereas a slight change in the visceral adipose area/volume may significantly alter the risk profile [9].”
BackgroundKammerlander, A. A., Lyass, A., Mahoney, T. F., Massaro, J. M., Long, M. T., Vasan, R. S., & Hoffmann, U. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019968 · Cited by 131
Self-citationObesity and cardiovascular disease: an ESC clinical consensus statement
Koskinas, K. C., Craenenbroeck, E. M. V., Antoniades, C. A., Blüher, M., Gorter, T. M., Hanssen, H., Marx, N., McDonagh, T. A., Mingrone, G., Rosengren, A., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae279 · Cited by 134
Exercise and ectopic fat in type 2 diabetes: A systematic review and meta-analysis
Sabag, A., Way, K. L., Keating, S. E., Sultana, R. N., O'Connor, H. T., Baker, M. K., Chuter, V., George, J., & Johnson, N. A. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.12.006 · Cited by 126
The pathophysiology of visceral adipose tissues in cardiometabolic diseases
Lee, M., & Kim, J. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116116 · Cited by 141
Fukuda, T., Bouchi, R., Terashima, M., Sasahara, Y., Asakawa, M., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., et al. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0279-y · Cited by 126
“As for body fat distribution, visceral fat (VF) accumulation has been more strongly associated with cardiometabolic risks than the body mass index (BMI), waist circumference, and abdominal subcutaneous fat accumulation [4, 5].”
BackgroundBandera, E. V., Maskarinec, G., Romieu, I., & John, E. M. (2015) · Advances in Nutrition · doi:10.3945/an.115.009647 · Cited by 121
“Visceral adipose tissue plays an important role in lipid and glucose metabolism due to the production of various hormones and cytokines (118) and is more strongly associated with an adverse metabolic risk profile than subcutaneous fat, even after controlling for standard anthropometric indexes (119).”
BackgroundBouchi, R., Asakawa, M., Ohara, N., Nakano, Y., Takeuchi, T., Murakami, M., Sasahara, Y., Numasawa, M., Minami, I., Izumiyama, H., et al. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000188 · Cited by 126
“5 6 However, a direct measure of visceral fat is limited due to the high cost of imaging procedures such as CT or MRI.”
BackgroundYoshida, D., Ninomiya, T., & Kiyohara, Y. (2004) · PubMed · Cited by 121
Chen, J., Li, L., Li, Y., Liang, X., Sun, Q., Yu, H., Zhong, J., Ni, Y., Chen, J., Zhao, Z., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0183-6 · Cited by 120
“cardiovascular disease and hypertension [4-6].”
Patients with Bardet-Biedl Syndrome Have Hyperleptinemia Suggestive of Leptin Resistance
Feuillan, P., Ng, D., Han, J. C., Sapp, J. C., Wetsch, K., Spaulding, E., Zheng, Y. C., Caruso, R. C., Brooks, B. P., Johnston, J. J., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2290 · Cited by 120
Relation of depot-specific adipose inflammation to insulin resistance in human obesity
Bigornia, S., Farb, M. G., Mott, M. M., Hess, D. T., Carmine, B. J., Fiscale, A. J., Joseph, L., Apovian, C. M., & Gokce, N. (2012) · Nutrition and Diabetes · doi:10.1038/nutd.2012.3 · Cited by 127
The Metabolic Syndrome as a Concept of Adipose Tissue Disease
Oda, E. (2008) · Hypertension Research · doi:10.1291/hypres.31.1283 · Cited by 120
Obesity and breast cancer: A case of inflamed adipose tissue
Kolb, R., & Zhang, W. (2020) · Cancers · doi:10.3390/cancers12061686 · Cited by 119
“Several studies have shown that obesity, as indicated by BMI, is associated with an increased risk of colon cancer [20–22], though other measurements of obesity, such as waist circumference or waist-to-hip ratio, are better predictors of colon cancer risk [23].”
BackgroundHigher Natriuretic Peptide Levels Associate With a Favorable Adipose Tissue Distribution Profile
Neeland, I. J., Winders, B. R., Ayers, C. R., Das, S. R., Chang, A. Y., Berry, J. D., Khera, A., McGuire, D. K., Vega, G. L., de Lemos, J. A., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.038 · Cited by 117
“For example, the accumulation of fat around the abdominal viscera and other ectopic sites such as the heart and liver is associated with multiple CVD risk factors (40) and the development of diabetes (31).”
BackgroundBhardwaj, S., Misra, A., Misra, R., Goel, K., Bhatt, S. P., Rastogi, K., Vikram, N. K., & Gulati, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024362 · Cited by 118
Lewis, T. T., Kravitz, H. M., Janssen, İ., & Powell, L. H. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq466 · Cited by 118
Ali, O., Cerjak, D., Kent, J. W., James, R., Blangero, J., & Zhang, Y. (2014) · Pediatric Obesity · doi:10.1111/j.2047-6310.2014.218.x · Cited by 118
Adiposity and hand osteoarthritis: the Netherlands Epidemiology of Obesity study
Visser, A. W., Ioan‐Facsinay, A., de Mutsert, R., Widya, R. L., Loef, M., Roos, A., le Cessie, S., den Heijer, M., Rosendaal, F. R., Kloppenburg, M., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4447 · Cited by 118
“In addition, visceral fat has been shown to be associated more strongly with obesity-related comorbidities, such as diabetes mellitus and the metabolic syndrome, and with markers of inflammation as compared with subcutaneous fat [15,16].”
BackgroundLiesenfeld, D. B., Grapov, D., Fahrmann, J. F., Haffa, M., Scherer, D., Tóth, R., Habermann, N., Böhm, J., Schrotz‐King, P., Gigic, B., et al. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.103804 · Cited by 119
Joppa, P., Tkáčová, R., Franssen, F. M. E., Hanson, C., Rennard, S. I., Silverman, E. K., McDonald, M., Calverley, P. M. A., Tal‐Singer, R., Spruit, M. A., et al. (2016) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2016.03.020 · Cited by 123
Inverse relationship between serum osteocalcin levels and visceral fat area in Chinese men
Bao, Y., Ma, X., Yang, R., Wang, F., Hao, Y., Dou, J., He, H., & Jia, W. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2906 · Cited by 116
Park, K. S., Lee, D., Lee, J.-E., Kim, Y. J., Jung, K. Y., Kim, K. M., Kwak, S. H., Choi, S. H., Park, K. S., Jang, H. C., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.10.014 · Cited by 115
Developmental and functional heterogeneity of white adipocytes within a single fat depot
Lee, K. Y., Luong, Q. V., Sharma, R., Dreyfuss, J. M., Ussar, S., & Kahn, C. R. (2018) · The EMBO Journal · doi:10.15252/embj.201899291 · Cited by 118
“…white adipose tissue (WAT) leads to central obesity and is associated with insulin resistance and increased risk of metabolic disease, whereas accumulation of subcutaneous WAT leads to peripheral obesity and may even be protective of metabolic syndrome (Janssen et al , 2002; Fox et al , 2007).”
Yim, J. Y., Kim, D., Lim, S. H., Park, M., Choi, S. H., Lee, C. H., Kim, S. S., & Cho, S. (2010) · Diabetes Care · doi:10.2337/dc10-0606 · Cited by 115
Hanley, A. J., Wagenknecht, L. E., Norris, J. M., Bryer‐Ash, M., Chen, Y. I., Anderson, A., Bergman, R. N., & Haffner, S. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1464-y · Cited by 117
Fang, L., Guo, F., Zhou, L., Stahl, R. D., & Grams, J. M. (2015) · Adipocyte · doi:10.1080/21623945.2015.1034920 · Cited by 118
“17-18 Although subcutaneous fat is the most well-studied adipose tissue depot in humans, visceral adiposity is highly associated with increased insulin resistance and metabolic syndrome.(19-24) Visceral fat is more metabolically active than the subcutaneous fat depot, and the association of visceral fat to metabolic s…”
BackgroundCatalán, V., Gómez‐Ambrosi, J., Rodrı́guez, A., Pérez-Hernández, A. I., Gurbindo, J., Ramírez, B., Méndez-Giménez, L., Rotellar, F., Valentí, V., Moncada, R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1191 · Cited by 114
“It has been established that VAT is strongly correlated with the metabolic abnormalities associated with obesity (43, 44).”
BackgroundTempleman, I., Smith, H. A., Chowdhury, E., Chen, Y.-C., Carroll, H., Johnson-Bonson, D., Hengist, A., Smith, R., Creighton, J., Clayton, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd8034 · Cited by 113
Minami, J.-I., Kondo, S., Yanagisawa, N., Odamaki, T., Xiao, J., Abe, F., Nakajima, S., Hamamoto, Y., Saitoh, S., & Shimoda, T. (2015) · Journal of Nutritional Science · doi:10.1017/jns.2015.5 · Cited by 114
“syndromes, and the excess accumulation of visceral fat is primarily involved in metabolic disorders((21,22)).”
Adipose Tissue in Metabolic Syndrome: Onset and Progression of Atherosclerosis
Luna‐Luna, M., Medina-Urrutia, A. X., Vargas‐Alarcón, G., Coss-Rovirosa, F., Vargas‐Barrón, J., & Pérez-Méndez, O. A. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.007 · Cited by 111
“Consequently, information on body fat distribution provides important insights about CAD risk (78).”
BackgroundImproving obesity and blood pressure
Tanaka, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0348-x · Cited by 113
Dâmaso, A. R., Campos, R. M. D. S., Caranti, D. A., de Piano, A., Fisberg, M., Foschini, D., Sanches, P. D. L., Tock, L., Lederman, H. M., Tufik, S., et al. (2014) · Journal of Sports Sciences · doi:10.1080/02640414.2014.900692 · Cited by 110
“Excess visceral adipose tissue is a well-established risk factor for cardiovascular disease, and a small decrement in visceral adipose tissue can significantly alter the risk profile (Fox et al., 2007).”
BackgroundAltered Upper Airway and Soft Tissue Structures in the New Zealand Obese Mouse
Brennick, M. J., Pack, A. I., Ko, K., Kim, E., Pickup, S., Maislin, G., & Schwab, R. J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1435oc · Cited by 110
Impact of General and Central Adiposity on Ventricular-Arterial Aging in Women and Men
Wohlfahrt, P., Redfield, M. M., López-Jiménez, F. A., Melenovský, V., Kane, G. C., Rodeheffer, R. J., & Borlaug, B. A. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.03.014 · Cited by 114
“Visceral fat mass is a major risk factor for cardiovascular disease (CVD) (11,12), whereas peripheral fat seems to confer a protective effect (13).”
BackgroundInfluentialRamírez‐Vélez, R., Correa‐Bautista, J. E., Tordecilla‐Sanders, A., Ojeda-Pardo, M. L., Cobo-Mejía, E. A., Castellanos-Vega, R. D. P., García‐Hermoso, A., González‐Jiménez, E., Schmidt‐RioValle, J., & González‐Ruíz, K. (2017) · Nutrients · doi:10.3390/nu9091009 · Cited by 111
“Understanding the specific fat distribution associated with MetS risk is important to improve the interventions that are currently more focused on overall weight loss [5,6].”
BackgroundGenetic and Environmental Interactions in Obesity and Type 2 Diabetes
Romao, I., & Roth, J. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.01.022 · Cited by 114
Adipose tissue changes in obesity and the impact on metabolic function
Sam, S., & Mazzone, T. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.008 · Cited by 113
Association of Subcutaneous and Visceral Adiposity With Albuminuria: The Framingham Heart Study
Foster, M. C., Hwang, S., Massaro, J. M., Hoffmann, U., DeBoer, I., Robins, S. J., Vasan, R. S., & Fox, C. S. (2010) · Obesity · doi:10.1038/oby.2010.308 · Cited by 111
Self-citationPoret, J. M., Souza‐Smith, F. M., Marcell, S. J., Gaudet, D. A., Tzeng, T. H., Braymer, H. D., Harrison‐Bernard, L. M., & Primeaux, S. D. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.280 · Cited by 112
Epidemiologic Methods in Physical Activity Studies
Lee, I. (2008) · doi:10.1093/acprof:oso/9780195183009.001.0001 · Cited by 110
Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile
Gupta, A., McGlone, M., Greenway, F. L., & Johnson, W. D. (2010) · Hypertension Research · doi:10.1038/hr.2010.91 · Cited by 109
Metabolically Healthy Obesity—Heterogeneity in Definitions and Unconventional Factors
Brandão, I., Martins, M. J., & Monteiro, R. (2020) · Metabolites · doi:10.3390/metabo10020048 · Cited by 117
Non-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications
Filardi, T., Catanzaro, G., Mardente, S., Zicari, A., Santangelo, C., Lenzi, A., Morano, S., & Ferretti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114020 · Cited by 113
“Omental adipose tissue is associated with a more adverse metabolic risk profile than subcutaneous adipose tissue [80] and could be involved in the development of insulin resistance [81].”
BackgroundAssociation of Lifestyle Factors With Abdominal Subcutaneous and Visceral Adiposity
Molenaar, E. A., Massaro, J. M., Jacques, P. F., Pou, K. M., Ellison, R. C., Hoffmann, U., Pencina, K. M., Shadwick, S. D., Vasan, R. S., O’Donnell, C. J., et al. (2008) · Diabetes Care · doi:10.2337/dc08-1382 · Cited by 113
Self-citationWeinstein, G., Davis‐Plourde, K. L., Himali, J. J., Zelber‐Sagi, S., Beiser, A., & Seshadri, S. S. (2019) · Liver International · doi:10.1111/liv.14161 · Cited by 115
Robins, S., Lyass, A., Zachariah, J., Massaro, J., & Vasan, R. (2011) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.219055 · Cited by 111
Self-citationFat distribution and mortality: The AGES‐Reykjavik study
Koster, A., Murphy, R. A., Eiríksdóttir, G., Aspelund, T., Sigurdsson, S. O., Lang, T., Gudnason, V. G., Launer, L. J., & Harris, T. B. (2015) · Obesity · doi:10.1002/oby.21028 · Cited by 107
“Numerous studies have shown that visceral adipose tissue is a metabolic risk factor (7; 8; 21).”
BackgroundDang, S., Leng, Y., Wang, Z., Xiao, X., Zhang, X., Wen, T., Gong, H.-Z., Hong, A., & Ma, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.28522 · Cited by 112
Aghamohammadzadeh, R., Withers, S., Lynch, F. M., Greenstein, A. S., Malik, R. A., & Heagerty, A. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01479.x · Cited by 107
Schlett, C. L., Massaro, J. M., Lehman, S. J., Bamberg, F., O’Donnell, C. J., Fox, C. S., & Hoffmann, U. (2009) · International Journal of Obesity · doi:10.1038/ijo.2008.267 · Cited by 106
Self-citation
Metadata
- Authors
- Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C.-Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A., D’Agostino, R. B., & O’Donnell, C. J.
- Affiliations
- Boston University (US)
- From the National Heart, Lung and Blood Institute’s Framingham Heart Study (C.S.F., C.J.O.), Framingham, Mass; Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine (C.S.F., K.M.P.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass; Boston University, Department of Mathematics (J.M.M.; R.B.D.) and School of Public Health, Division of Biostatistics (C.-Y.L., L.A.C.), Boston, Mass; Radiology Department (U.H.) and Department of Medicine (J.B.M., C.J.O.),...
- ORCID
- Venue
- Circulation
- Published
- 2007-07-03
- Volume
- 116
- Issue
- 1
- Pages
- 39-48
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1989400130
- Cited by
- 2,882
- References
- 78
- Citations by year
- 2026: 102 · 2025: 163 · 2024: 172 · 2023: 164 · 2022: 190 · 2021: 196 · 2020: 162 · 2019: 161 · 2018: 161 · 2017: 157 · 2016: 182 · 2015: 182 · 2014: 184 · 2013: 151 · 2012: 124
- FWCI
- 68.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (N01‐HC25195, K24HL004334)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007529)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- visceral adipose tissue, subcutaneous adipose tissue, metabolic risk factors, metabolic syndrome, sex differences, hypertension, impaired fasting glucose, diabetes mellitus, body fat distribution, obesity, body mass index, waist circumference
- MeSH terms
- Adult, Calcium, Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus, Female, Humans, Hypercholesterolemia, Hyperglycemia, Hypertension, Male, Middle Aged, Obesity, Organ Size, Risk, Sex Factors, United States, Hypertriglyceridemia, Cohort Studies, Comorbidity, Body Mass Index, Glucose Intolerance, Metabolic Syndrome, Tomography, Spiral Computed, Intra-Abdominal Fat, Overweight, Subcutaneous Fat, Abdominal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review